In Russia, as in many countries, women who use drugs face profound structural and individual challenges to accessing essential health care. According to the UN Office on Drugs and Crime, Russia is home to 1.6 million injecting drug users, and women are believed to make up as many as 40 percent. Yet local harm reduction groups report as few as one in six of their clients is female.
This new fact sheet documents how five harm reduction projects in cities and towns throughout Russia have shown that targeted, gender-sensitive programming can promote higher participation amongst women drug users and ultimately enable safer behavior. Indeed, where such programs exist, the proportion of female-to-male clients soon draws even. Some of the gender-sensitive initiatives detailed include:
- Women-only drop-in centers
- Peer-based outreach efforts that promote confidentiality and personal safety
- Referrals to trained, friendly physicians at local AIDS clinics and maternity centers
- Housing support and legal services
A rapid expansion of gender-sensitive harm reduction programs and the number of participants they serve is essential for improved access of vulnerable women and their children to lifesaving services. By Women, For Women provides an important guide to the necessary elements to ensure this growth is effective in Russia and elsewhere.
Download
-
By Women, For Women (675.96 Kb pdf file)
Download the fact sheet.
Read more
Drug Policy
The Prescription for Saving Lives
A person dies every five minutes from overdose in the United States. We have the means to dramatically reduce those numbers. But the medication naloxone is suddenly scarce and prices are too high. What needs to happen next to save lives.
Faith and Healing
Q&A: Preaching Harm Reduction
By bringing harm reduction to the faith community, Faith in Public Life is using the church to save lives in the face of the overdose crisis.
Event Recap
The Way the U.S. Regulates Methadone Isn’t Working
A new documentary takes a close look at how methadone is used in the United States today, while raising profound questions about the purpose of antidrug policies and the benefits of harm reduction.